Director- Research Scientist - Early Phase Medical Affairs Research

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.

Actual compensation will depend on a candidate’s education, experience, skills, and geographic location.  The anticipated wage for this position is

$168,000 - $294,800

Organizational Overview 

At Lilly, we believe in the talent of our workforce. One of the best ways to utilize and develop that talent is to use our existing workforce to fill new and/or open positions. If you are looking for a new position within Lilly, you can view and apply to open roles posted in the internal job posting system. You must meet the minimum qualifications outlined in the job description and have/obtain work authorization in the country the position is located in order to be considered. When applying internally for a position, your current supervisor will receive notification that you have applied to the position. We encourage employees to discuss the opportunity with their supervisor prior to applying. 

Position Summary: 

The oncology Early Phase Medical Affairs Research Scientist leads the development and execution of early phase medical affairs strategic plans that craft the scientific story, create program awareness tools, and channels scientific content to stakeholders. The role provides expertise on current treatment practices and emerging mechanisms that may affect future standards of care and translates impact to early phase programs. This role leads the creation of a suite of scientific resources and digital materials to drive external awareness of the oncology pipeline.  The position engages with external customers to facilitate the sharing of scientific information and to more clearly understand the treatment landscape.  Additionally, the role identifies evidence gaps and works cross-functionally to implement solutions.  Ultimately, the scientist builds the medical affairs foundation for early phase programs and ensures a smooth transition of medical affairs deliverables to late phase teams to accelerate launch readiness. 

 

 

Roles and Responsibilities of the Position: 

• Develop, execute, and maintain medical affairs strategic plans for the radioligand therapy portfolio from clinic entry through commercial decision 

• Initiate the creation and ensure maintenance of scientific resources for early phase programs (i.e. mechanism of action imagery, trial awareness materials, congress materials, etc.) 

• Lead innovation readiness planning and integrated evidence generation workstreams; identify publication opportunities and interface with cross-functional teams to deliver innovative solutions 

• Leverage scientific expertise and bring relevant external clinical insights to early phase teams to inform on program impacts 

• Engage with external customers (i.e. TLs, investigators, patient advocacy) to facilitate the sharing of scientific information and understand external landscape evolution 

• Lead training on the early phase portfolio and relevant resources 

• Transfer program knowledge and deliverables to future late phase teams for early launch planning 

 

Basic Qualifications:  

• Advanced scientific-related graduate degree such as: MD, MS, PharmD, PhD, or MSN with advanced clinical specialty 

Additional skills 

• Oncology and radioligand experience highly preferred 

• 5-10 years related experience in the pharmaceutical or biotech industry 

• Medical affairs and/or clinical development experience highly preferred 

• Demonstrated ability to think on an enterprise level